Join to View Full Profile
505 Parnassus Ave550 16th StreetSan Francisco, CA 94143
Phone+1 415-476-2188
Fax+1 415-502-4867
Dr. Cowan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Residency, Pediatrics, 1976 - 1978
Duke University HospitalResidency, Surgery, 1970 - 1972
Perelman School of Medicine at the University of PennsylvaniaClass of 1970
Certifications & Licensure
CA State Medical License 1975 - 2027
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease Start of enrollment: 2005 Apr 01
- Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders Start of enrollment: 2005 Jan 01
- Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission Start of enrollment: 2000 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Younger children with nonmalignant disease have increased incidence of mixed myeloid chimerism after allogeneic hematopoietic cell transplantation with busulfan-based ...Christopher C Dvorak, William C Temple, Gabriel Salinas Cisneros, Julia Chu, Lena E Winestone
Transplantation and Cellular Therapy. 2025-04-01 - Late effects following hematopoietic cell transplantation for severe combined immunodeficiency: critical factors and therapeutic options.Hesham Eissa, Morton J Cowan, Jennifer Heimall
Expert Review of Clinical Immunology. 2025-01-01 - High symptom burden in female X-linked chronic granulomatous disease carriers.Mary Ann Miranda, Athanasios Tsalatsanis, Jessica R Trotter, Danielle E Arnold, Jacqueline D Squire
Clinical Immunology. 2024-11-01
Journal Articles
- Allograft and Patient Survival After Sequential HSCT and Kidney Transplantation from the Same Donor– a Multicenter AnalysisMorton J Cowan, Tepsiri Chongkrairatanakul, American journal of transplantation
Abstracts/Posters
- Lentiviral Gene Therapy with Low Dose Busulfan for Infants with X-SCID Results in the Development of a Functional Normal Immune System: Interim Results of an Ongoing P...Morton J Cowan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Enhanced Transduction Lentivector Gene Therapy for Treatment of Older Patients with X-Linked Severe Combined ImmunodeficiencyMorton J Cowan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell TransplantsMorton J Cowan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Other
- T cell negative, B cell negative, NK cell positive severe combined immunodeficiencyCowan MJ
http://www.uptodate.com/contents/t-cell-negative-b-cell-negative-nk-cell-positive-severe-combined-im
UpToDate, Wolters Kluwer Health - 2012-10-12
Press Mentions
Study Finds HIV-Containing Gene Therapy Restores Immunity in "Bubble Baby" DiseaseMay 12th, 2021
UCSF Participates in Experimental Therapy Trial for Infants with Rare Genetic Disease SCIDApril 30th, 2019
Docs Use HIV, Gene Remedy to Treatment Bubble Boy IllnessApril 21st, 2019- Join now to see all
Grant Support
- Primary Immune Deficiency Treatment Consortium Annual Scientific MeetingNational Institute Of Allergy And Infectious Diseases2011–2012
- Primary Immune Deficiency Treatment Consortium Administrative UnitNational Institute Of Allergy And Infectious Diseases2011
- Clinical Sites ConsortiumsNational Institute Of Allergy And Infectious Diseases2011
- Primary Immune Deficiency Treatment ConsortiumNational Institute Of Allergy And Infectious Diseases2009–2011
- ID Of DNA PK Dependent Kinase Sites Of Phosphorylation On Artemis ProteinNational Center For Research Resources2004–2005
- Bone Marrow Stem Cell Transplantation For ChildrenNational Center For Research Resources2004–2005
- Tolerance Post In Utero TransplantationNational Heart, Lung, And Blood Institute1998–2005
- Busulfan Pharmacokinetics In Patients Undergoing Bone Marrow TransplantationNational Center For Research Resources2000–2002
- Gene Linkage Study Of Immunodeficiency In Navajo IndiansNational Institute Of Allergy And Infectious Diseases1993–2001
- Tolerance Induction In Utero Renal TransplantationNational Center For Research Resources1997
- Rhesus Model Of In Utero Stem Cell TransplantationNational Center For Research Resources1996
- Recruitment Of Hematopoietic Stem Cells W/ Stem Cell Factor &G CSFNational Center For Research Resources1996
- Induction Of Tolerance In Marrow TransplantationNational Institute Of Allergy And Infectious Diseases1990–1994
- HIV Infection In Children Of IV Drug Abusing WomenNational Institute On Drug Abuse1990–1992
- AIDS Associated Retrovirus (ARV) Infection In ChildrenNational Institute On Drug Abuse1986–1988
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
